Catalent handed two Form 483s for Maryland gene therapy sitesnews2025-12-19T12:25:40+00:00December 19th, 2025|Endpoints News|
Alnylam, INCOG and Novartis expand in US; Ember gets $16.5M Series Anews2025-12-18T14:57:00+00:00December 18th, 2025|Endpoints News|
Moderna lands CEPI as new backer for its pandemic flu programnews2025-12-18T12:00:43+00:00December 18th, 2025|Endpoints News|
European Commission unveils EU Biotech Act as it lags behind other countries news2025-12-17T18:45:32+00:00December 17th, 2025|Endpoints News|
Senate passes Biosecure Act aimed at Chinese suppliersnews2025-12-17T18:25:23+00:00December 17th, 2025|Endpoints News|
Novo Nordisk hit with FDA warning letter over acquired Catalent factorynews2025-12-17T15:41:07+00:00December 17th, 2025|Endpoints News|
House backs Biosecure Act aimed at Chinese companiesnews2025-12-11T09:52:38+00:00December 11th, 2025|Endpoints News|
Adare Pharma shutters Philadelphia site and lays off over 100 staffersnews2025-12-10T16:39:05+00:00December 10th, 2025|Endpoints News|
Eli Lilly earmarks $6B for GLP-1 pill factory in Alabamanews2025-12-09T20:30:05+00:00December 9th, 2025|Endpoints News|
J&J-backed Cellular Origins raises $40M for cell therapy manufacturing news2025-12-09T17:53:07+00:00December 9th, 2025|Endpoints News|
